156 related articles for article (PubMed ID: 31286348)
21. Neuroprotective Effect of Curcumin on the Nigrostriatal Pathway in a 6-Hydroxydopmine-Induced Rat Model of Parkinson's Disease is Mediated by α7-Nicotinic Receptors.
El Nebrisi E; Javed H; Ojha SK; Oz M; Shehab S
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33023066
[TBL] [Abstract][Full Text] [Related]
22. Bis(het)aryl-1,2,3-triazole quinuclidines as α7 nicotinic acetylcholine receptor ligands: Synthesis, structure affinity relationships, agonism activity, [
Ouach A; Vercouillie J; Bertrand E; Rodrigues N; Pin F; Serriere S; Boiaryna L; Chartier A; Percina N; Tangpong P; Gulhan Z; Mothes C; Deloye JB; Guilloteau D; Page G; Suzenet F; Buron F; Chalon S; Routier S
Eur J Med Chem; 2019 Oct; 179():449-469. PubMed ID: 31271958
[TBL] [Abstract][Full Text] [Related]
23. Construction and evaluation of multitracer small-animal PET probabilistic atlases for voxel-based functional mapping of the rat brain.
Casteels C; Vermaelen P; Nuyts J; Van Der Linden A; Baekelandt V; Mortelmans L; Bormans G; Van Laere K
J Nucl Med; 2006 Nov; 47(11):1858-66. PubMed ID: 17079820
[TBL] [Abstract][Full Text] [Related]
24. Lessons learned about [F-18]-AV-1451 off-target binding from an autopsy-confirmed Parkinson's case.
Marquié M; Verwer EE; Meltzer AC; Kim SJW; Agüero C; Gonzalez J; Makaretz SJ; Siao Tick Chong M; Ramanan P; Amaral AC; Normandin MD; Vanderburg CR; Gomperts SN; Johnson KA; Frosch MP; Gómez-Isla T
Acta Neuropathol Commun; 2017 Oct; 5(1):75. PubMed ID: 29047416
[TBL] [Abstract][Full Text] [Related]
25. [(125)I]Iodo-ASEM, a specific in vivo radioligand for α7-nAChR.
Gao Y; Mease RC; Olson TT; Kellar KJ; Dannals RF; Pomper MG; Horti AG
Nucl Med Biol; 2015 May; 42(5):488-493. PubMed ID: 25687449
[TBL] [Abstract][Full Text] [Related]
26. Brain α7 nicotinic acetylcholine receptors in MPTP-lesioned monkeys and parkinsonian patients.
Morissette M; Morin N; Grégoire L; Rajput A; Rajput AH; Di Paolo T
Biochem Pharmacol; 2016 Jun; 109():62-69. PubMed ID: 27038656
[TBL] [Abstract][Full Text] [Related]
27. Fluorodopa is a Promising Fluorine-19 MRI Probe for Evaluating Striatal Dopaminergic Function in a Rat Model of Parkinson's Disease.
Yanagisawa D; Oda K; Inden M; Morikawa S; Inubushi T; Taniguchi T; Hijioka M; Kitamura Y; Tooyama I
J Neurosci Res; 2017 Jul; 95(7):1485-1494. PubMed ID: 27792255
[TBL] [Abstract][Full Text] [Related]
28. Radiochemical synthesis and in vivo evaluation of [18F]AZ11637326: an agonist probe for the α7 nicotinic acetylcholine receptor.
Ravert HT; Dorff P; Foss CA; Mease RC; Fan H; Holmquist CR; Phillips E; McCarthy DJ; Heys JR; Holt DP; Wang Y; Endres CJ; Dannals RF; Pomper MG
Nucl Med Biol; 2013 Aug; 40(6):731-9. PubMed ID: 23680470
[TBL] [Abstract][Full Text] [Related]
29. In vivo imaging of Α7 nicotinic receptors as a novel method to monitor neuroinflammation after cerebral ischemia.
Colás L; Domercq M; Ramos-Cabrer P; Palma A; Gómez-Vallejo V; Padro D; Plaza-García S; Pulagam KR; Higuchi M; Matute C; Llop J; Martín A
Glia; 2018 Aug; 66(8):1611-1624. PubMed ID: 29528142
[TBL] [Abstract][Full Text] [Related]
30. Microwave-assisted radiosynthesis of [(18) F]ASEM, a radiolabeled α7-nicotinic acetylcholine receptor antagonist.
Ravert HT; Holt DP; Gao Y; Horti AG; Dannals RF
J Labelled Comp Radiopharm; 2015 Apr; 58(4):180-2. PubMed ID: 25720955
[TBL] [Abstract][Full Text] [Related]
31. In vivo imaging of neuromelanin in Parkinson's disease using 18F-AV-1451 PET.
Hansen AK; Knudsen K; Lillethorup TP; Landau AM; Parbo P; Fedorova T; Audrain H; Bender D; Østergaard K; Brooks DJ; Borghammer P
Brain; 2016 Jul; 139(Pt 7):2039-49. PubMed ID: 27190023
[TBL] [Abstract][Full Text] [Related]
32. Decrease of nicotinic receptors in the nigrostriatal system in Parkinson's disease.
Kas A; Bottlaender M; Gallezot JD; Vidailhet M; Villafane G; Grégoire MC; Coulon C; Valette H; Dollé F; Ribeiro MJ; Hantraye P; Remy P
J Cereb Blood Flow Metab; 2009 Sep; 29(9):1601-8. PubMed ID: 19491921
[TBL] [Abstract][Full Text] [Related]
33. Extensive exploration of a novel rat model of Parkinson's disease using partial 6-hydroxydopamine lesion of dopaminergic neurons suggests new therapeutic approaches.
Vetel S; Sérrière S; Vercouillie J; Vergote J; Chicheri G; Deloye JB; Dollé F; Bodard S; Tronel C; Nadal-Desbarats L; Lefèvre A; Emond P; Chalon S
Synapse; 2019 Mar; 73(3):e22077. PubMed ID: 30368914
[TBL] [Abstract][Full Text] [Related]
34. Nigrostriatal dopamine transporter availability in early Parkinson's disease.
Fazio P; Svenningsson P; Cselényi Z; Halldin C; Farde L; Varrone A
Mov Disord; 2018 Apr; 33(4):592-599. PubMed ID: 29436751
[TBL] [Abstract][Full Text] [Related]
35. Development of radioligands for the imaging of α7 nicotinic acetylcholine receptors with positron emission tomography.
Brust P; Peters D; Deuther-Conrad W
Curr Drug Targets; 2012 May; 13(5):594-601. PubMed ID: 22300025
[TBL] [Abstract][Full Text] [Related]
36. Nurr1, Pitx3, and α7 nAChRs mRNA Expression in Nigral Tissue of Rats with Pedunculopontine Neurotoxic Lesion.
Blanco-Lezcano L; Alberti-Amador E; González-Fraguela ME; Larrea GZ; Pérez-Serrano RM; Jiménez-Luna NA; Serrano-Sánchez T; Francis-Turner L; Camejo-Rodriguez D; Vega-Hurtado Y
Medicina (Kaunas); 2019 Sep; 55(10):. PubMed ID: 31547185
[No Abstract] [Full Text] [Related]
37. Current status and future challenges of brain imaging with (18)F-DOPA PET for movement disorders.
Calabria FF; Calabria E; Gangemi V; Cascini GL
Hell J Nucl Med; 2016; 19(1):33-41. PubMed ID: 26929938
[TBL] [Abstract][Full Text] [Related]
38. [Possible involvement of neuronal nicotinic acetylcholine receptors in compensatory brain mechanisms at early stages of Parkinson's disease].
Kryukova EV; Shelukhina IV; Kolacheva AA; Alieva AK; Shadrina MI; Slominsky PA; Kasheverov IE; Utkin YN; Ugrumov MV; Tsetlin VI
Biomed Khim; 2017 May; 63(3):241-247. PubMed ID: 28781257
[TBL] [Abstract][Full Text] [Related]
39. PET Imaging of the P2X7 Ion Channel with a Novel Tracer [
Berdyyeva T; Xia C; Taylor N; He Y; Chen G; Huang C; Zhang W; Kolb H; Letavic M; Bhattacharya A; Szardenings AK
Mol Imaging Biol; 2019 Oct; 21(5):871-878. PubMed ID: 30632003
[TBL] [Abstract][Full Text] [Related]
40. α7 nicotinic acetylcholine receptor mediated neuroprotection in Parkinson's disease.
Kawamata J; Suzuki S; Shimohama S
Curr Drug Targets; 2012 May; 13(5):623-30. PubMed ID: 22300030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
